These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 27323073)
1. Nuclear magnetic resonance-based study reveals the metabolomics profile of nasopharyngeal carcinoma. Wang Y; Luo X; Zhang GH; Li SL Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323073 [TBL] [Abstract][Full Text] [Related]
3. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique. Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139 [TBL] [Abstract][Full Text] [Related]
4. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics. Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476 [TBL] [Abstract][Full Text] [Related]
5. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. Zhou A; Ni J; Xu Z; Wang Y; Lu S; Sha W; Karakousis PC; Yao YF J Proteome Res; 2013 Oct; 12(10):4642-9. PubMed ID: 23980697 [TBL] [Abstract][Full Text] [Related]
6. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease. Bjerrum JT; Steenholdt C; Ainsworth M; Nielsen OH; Reed MA; Atkins K; Günther UL; Hao F; Wang Y BMC Med; 2017 Oct; 15(1):184. PubMed ID: 29032767 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma. Tan G; Liu Q; Tang X; Kang T; Li Y; Lu J; Zhao X; Tang F BMC Cancer; 2016 Mar; 16():241. PubMed ID: 26995190 [TBL] [Abstract][Full Text] [Related]
8. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. Feng X; Lin J; Xing S; Liu W; Zhang G BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425 [TBL] [Abstract][Full Text] [Related]
9. [A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma]. Huang XW; Zhou W; Chen J; Chu HQ; Xiao CW; Hua XY; Zhang P; Li HQ; Cui YH Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):509-12. PubMed ID: 21924105 [TBL] [Abstract][Full Text] [Related]
10. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705 [TBL] [Abstract][Full Text] [Related]
11. Quantitative NMR-Based Metabolomics on Tissue Biomarkers and Its Translation into In Vivo Magnetic Resonance Spectroscopy. Serkova NJ; Davis DM; Steiner J; Agarwal R Methods Mol Biol; 2019; 1978():369-387. PubMed ID: 31119675 [TBL] [Abstract][Full Text] [Related]
12. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma. Liao Z; Zhao L; Zhong F; Zhou Y; Lu T; Liu L; Gong X; Li J; Rao J Rapid Commun Mass Spectrom; 2023 Mar; 37(6):e9469. PubMed ID: 36593223 [TBL] [Abstract][Full Text] [Related]
13. A metabolic map and artificial intelligence-aided identification of nasopharyngeal carcinoma via a single-cell Raman platform. Xu J; Chen D; Wu W; Ji X; Dou X; Gao X; Li J; Zhang X; Huang WE; Xiong D Br J Cancer; 2024 Jun; 130(10):1635-1646. PubMed ID: 38454165 [TBL] [Abstract][Full Text] [Related]
14. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia. Zhang Y; Zhang H; Rong S; Bian C; Yang Y; Pan H Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2449-2457. PubMed ID: 34154888 [TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance-based metabolomics reveals similar metabolomics profiles in undifferentiated peripheral spondyloarthritis and reactive arthritis. Ahmed S; Dubey D; Chowdhury A; Chaurasia S; Guleria A; Kumar S; Singh R; Kumar D; Misra R Int J Rheum Dis; 2019 Apr; 22(4):725-733. PubMed ID: 30810278 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum granulysin as a potential biomarker for nasopharyngeal carcinoma. Lin J; Huang Y; Zhang L; Tang W; Li X; Wang X; Liu W Clin Chim Acta; 2016 Feb; 454():72-6. PubMed ID: 26751807 [TBL] [Abstract][Full Text] [Related]
17. Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial. Tang T; Zhou Z; Chen M; Li N; Sun J; Chen Z; Xiao T; Wang X; Zhang L; Wang Y; Zhang H; Zheng X; Chen B; Ye F; Guan J Clin Cancer Res; 2024 Jul; 30(14):2925-2936. PubMed ID: 38713248 [TBL] [Abstract][Full Text] [Related]
18. Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Jung J; Kim SH; Lee HS; Choi GS; Jung YS; Ryu DH; Park HS; Hwang GS Clin Exp Allergy; 2013 Apr; 43(4):425-33. PubMed ID: 23517038 [TBL] [Abstract][Full Text] [Related]